MAPK1 and ductal breast carcinoma in situ: However, the two lines of ERK2-knockout DCIS-iFGFR1 cells grew much slower than DCIS-iFGFR1 control cells and ERK1-knockout DCIS-iFGFR1 cells in both the absence and presence of AP20187 (Fig.